Global Self-Injections Market By Type (Syringe Without Needle, Automatic Syringe, Pen Type Syringe, and Wearable Syringe), By Application (Hospital, Clinic, and Pharm), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 137399
- 18-Dec
- PDF/PPT/Word
-
Report Details
The report on Self-Injections Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global self-injections market is segmented on the basis of Type, Application, and geography.
The Worldwide market for Self-Injections Market is expected to grow at a CAGR of roughly x.x% over the next nine years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.
Self-Injections Market Scope:
By type, the market is segmented into Syringe Without Needle, Automatic Syringe, Pen Type Syringe, and Wearable Syringe. By Application, the market is divided into Hospital, Clinic, and Pharm.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Elcam Medicalcompany Overview, Bespak, Sanofi, Sandoz International Gmbh, Unilife Corporation, West Pharmaceutical Services, West Pharmaceutical Services, Impax Laboratories, Penjet Corporation, Crossject Needle-Free Injection Systems, Wilhelm Haselmeier Gmbh & Co. Kg, Antares Pharma, Becton, Gerresheimer Ag, Mylan N.V, Novo Nordisk, Owen Mumford, Pharmajet, Shl Group, and Ypsomed.Key Market Segments
Type
Syringe Without Needle
Automatic Syringe
Pen Type Syringe
Wearable SyringeApplication
Hospital
Clinic
PharmKey Market Players included in the report:
Elcam Medicalcompany Overview
Bespak
Sanofi
Sandoz International Gmbh
Unilife Corporation
West Pharmaceutical Services
West Pharmaceutical Services
Impax Laboratories
Penjet Corporation
Crossject Needle-Free Injection Systems
Wilhelm Haselmeier Gmbh & Co. Kg
Antares Pharma
Becton
Gerresheimer Ag
Mylan N.V
Novo Nordisk
Owen Mumford
Pharmajet
Shl Group
YpsomedReasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Self-Injections Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Self-Injections Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Self-Injections Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Self-Injections Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Self-Injections Market together side their company profiles, SWOT analysis, latest advancements, and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Self-Injections Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Self-Injections sub-markets, depending on key regions (various vital states).
To analyze Self-Injections Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Self-Injections Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2014 to 2019, and also prediction to 2028.
Primary worldwide Self-Injections Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. Self-Injections Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Self-Injections Market Overview3.1. Self-Injections Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges 3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Production Analysis by Region/Company
3.9. Industry chain Analysis
3.10. Marketing Strategy4. Global Self-Injections Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Self-Injections Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Syringe Without Needle4.4. Automatic Syringe
4.5. Pen Type Syringe
4.6. Wearable Syringe5. Global Self-Injections Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
5.1. Global Self-Injections Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Hospital5.4. Clinic
5.5. Pharm6. Global Self-Injections Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
6.1. North America
6.1.1. North America Self-Injections Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2.1. Europe
6.2.1. Europe Self-Injections Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Spain
6.2.1.7. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Self-Injections Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia-Pacific6.4. Latin America
6.4.1. Latin America Self-Injections Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Self-Injections Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Self-Injections Market Competitive Landscape, Market Share Analysis, and Company Profiles7.1. Market Share Analysis
7.2. Company Profiles
7.3. Elcam Medicalcompany Overview7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments 7.4. Bespak7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments 7.5. Sanofi7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments 7.6. Sandoz International Gmbh7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments 7.7. Unilife Corporation7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments 7.8. West Pharmaceutical Services7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments 7.9. West Pharmaceutical Services7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments 7.10. Impax Laboratories7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments 7.11. Penjet Corporation7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments 7.12. Crossject Needle-Free Injection Systems7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments 7.13. Wilhelm Haselmeier Gmbh & Co. Kg7.13.1. Company Overview
7.13.2. Financial Highlights
7.13.3. Product Portfolio
7.13.4. SWOT Analysis
7.13.5. Key Strategies and Developments 7.14. Antares Pharma7.14.1. Company Overview
7.14.2. Financial Highlights
7.14.3. Product Portfolio
7.14.4. SWOT Analysis
7.14.5. Key Strategies and Developments 7.15. Becton7.15.1. Company Overview
7.15.2. Financial Highlights
7.15.3. Product Portfolio
7.15.4. SWOT Analysis
7.15.5. Key Strategies and Developments 7.16. Gerresheimer Ag7.16.1. Company Overview
7.16.2. Financial Highlights
7.16.3. Product Portfolio
7.16.4. SWOT Analysis
7.16.5. Key Strategies and Developments 7.17. Mylan N.V7.17.1. Company Overview
7.17.2. Financial Highlights
7.17.3. Product Portfolio
7.17.4. SWOT Analysis
7.17.5. Key Strategies and Developments 7.18. Novo Nordisk7.18.1. Company Overview
7.18.2. Financial Highlights
7.18.3. Product Portfolio
7.18.4. SWOT Analysis
7.18.5. Key Strategies and Developments 7.19. Owen Mumford7.19.1. Company Overview
7.19.2. Financial Highlights
7.19.3. Product Portfolio
7.19.4. SWOT Analysis
7.19.5. Key Strategies and Developments 7.20. Pharmajet7.20.1. Company Overview
7.20.2. Financial Highlights
7.20.3. Product Portfolio
7.20.4. SWOT Analysis
7.20.5. Key Strategies and Developments 7.21. Shl Group7.21.1. Company Overview
7.21.2. Financial Highlights
7.21.3. Product Portfolio
7.21.4. SWOT Analysis
7.21.5. Key Strategies and Developments 7.22. Ypsomed7.22.1. Company Overview
7.22.2. Financial Highlights
7.22.3. Product Portfolio
7.22.4. SWOT Analysis
7.22.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample